World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

World Top Biotechnology Companies in 2026
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.

  1. Aimmune Therapeutics

    World Rank (Aug-2026)
    4,918
    World Rank (Jan-05-2024)
    4,918
    World Rank (Jul-30-2023)
    4,918
    World Rank (Dec-25-2022)
    4,918
    World Rank (Jan-07-2022)
    4,918
    Annual Operating Income in USD
    -250 Million USD
    Annual Net Income in USD
    -248 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    USA
    Company Profile
    Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies. Headquarters is in USA.
    Company Website
    AIMMUNE THERAPEUTICS INC

  2. Immunome Inc.

    World Rank (Aug-2026)
    4,957
    Market Cap (Aug-2026)
    3.089 Billion USD
    World Rank (Jan-05-2024)
    12,539
    Market Cap (Jan-05-2024)
    0.505 Billion USD
    World Rank (Jul-30-2023)
    22,195
    Market Cap (Jul-30-2023)
    0.091 Billion USD
    World Rank (Dec-25-2022)
    26,459
    Market Cap (Dec-25-2022)
    0.038 Billion USD
    World Rank (Jan-07-2022)
    20,901
    Market Cap (Jan-07-2022)
    0.14 Billion USD
    Annual Revenue in USD
    7 Million USD
    Annual Operating Income in USD
    -224 Million USD
    Annual Net Income in USD
    -212 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    IMMUNOME INC.

  3. Tarsus Pharmaceuticals Inc.

    World Rank (Aug-2026)
    5,005
    Market Cap (Aug-2026)
    3.037 Billion USD
    World Rank (Jan-05-2024)
    10,892
    Market Cap (Jan-05-2024)
    0.662 Billion USD
    World Rank (Jul-30-2023)
    11,446
    Market Cap (Jul-30-2023)
    0.614 Billion USD
    World Rank (Dec-25-2022)
    14,096
    Market Cap (Dec-25-2022)
    0.387 Billion USD
    World Rank (Jan-07-2022)
    13,834
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    451 Million USD
    Annual Operating Income in USD
    -71 Million USD
    Annual Net Income in USD
    -66 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Tarsus Pharmaceuticals is a Late Clinical Stage Biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address highly prevalent conditions with limited treatment options. It is having 20 employees as on 2019. The headquarters is in USA.
    Company Website
    TARSUS PHARMACEUTICALS, INC.

  4. Grail

    World Rank (Aug-2026)
    5,011
    Market Cap (Aug-2026)
    3.031 Billion USD
    World Rank (Jan-05-2024)
    3,527
    World Rank (Jul-30-2023)
    3,527
    World Rank (Dec-25-2022)
    3,527
    World Rank (Jan-07-2022)
    3,527
    Annual Revenue in USD
    147 Million USD
    Annual Operating Income in USD
    -562 Million USD
    Annual Net Income in USD
    -408 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    GRAIL is healthcare company and its mission is to detect cancer early, when it can be cured
    Company Website
    GRAIL

  5. Keymed Biosciences Inc.

    World Rank (Aug-2026)
    5,026
    Market Cap (Aug-2026)
    3.018 Billion USD
    World Rank (Jan-05-2024)
    6,778
    Market Cap (Jan-05-2024)
    1.493 Billion USD
    World Rank (Jul-30-2023)
    5,733
    Market Cap (Jul-30-2023)
    2.008 Billion USD
    World Rank (Dec-25-2022)
    5,744
    Market Cap (Dec-25-2022)
    1.837 Billion USD
    World Rank (Jan-07-2022)
    9,089
    Market Cap (Jan-07-2022)
    1.06 Billion USD
    Headquarters Country
    China
    Company Website
    KEYMED BIOSCIENCES INC.

  6. Zai Lab

    World Rank (Aug-2026)
    5,125
    Market Cap (Aug-2026)
    2.908 Billion USD
    World Rank (Jan-05-2024)
    4,807
    Market Cap (Jan-05-2024)
    2.622 Billion USD
    World Rank (Jul-30-2023)
    4,184
    Market Cap (Jul-30-2023)
    3.176 Billion USD
    World Rank (Dec-25-2022)
    4,923
    Market Cap (Dec-25-2022)
    2.320 Billion USD
    World Rank (Jan-07-2022)
    3,121
    Market Cap (Jan-07-2022)
    5.31 Billion USD
    Annual Revenue in USD
    144 Million USD
    Annual Net Income in USD
    -704 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Stock Category
    China ADRs
    Yahoo @ Nasdaq
    Company Profile

    Zai Lab is an Innovative and Research Based Commercial Stage Biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. It is having 900 employees as on 2020. The headquarters is in China.

    Company Website
    ZAI LAB LIMITED

  7. Provention Bio

    World Rank (Aug-2026)
    5,145
    World Rank (Jan-05-2024)
    5,145
    World Rank (Jul-30-2023)
    5,145
    Market Cap (Jul-30-2023)
    2.370 Billion USD
    World Rank (Dec-25-2022)
    9,337
    Market Cap (Dec-25-2022)
    0.839 Billion USD
    World Rank (Jan-07-2022)
    16,071
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Revenue in USD
    13 Million USD
    Annual Operating Income in USD
    -128 Million USD
    Annual Net Income in USD
    -114 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    USA
    Company Profile

    Provention Bio is a Clinical Stage Biopharmaceutical company. The headquarters is in USA.

    Company Website
    PROVENTION BIO

  8. Nurix Therapeutics Inc.

    World Rank (Aug-2026)
    5,235
    Market Cap (Aug-2026)
    2.807 Billion USD
    World Rank (Jan-05-2024)
    12,883
    Market Cap (Jan-05-2024)
    0.478 Billion USD
    World Rank (Jul-30-2023)
    13,148
    Market Cap (Jul-30-2023)
    0.469 Billion USD
    World Rank (Dec-25-2022)
    12,559
    Market Cap (Dec-25-2022)
    0.489 Billion USD
    World Rank (Jan-07-2022)
    8,355
    Market Cap (Jan-07-2022)
    1.23 Billion USD
    Annual Revenue in USD
    84 Million USD
    Annual Operating Income in USD
    -286 Million USD
    Annual Net Income in USD
    -264 Million USD
    Annual Results for Period Ending
    For year ending November-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Nurix Therapeutics is a  Biopharmaceutical company discovers drugs that harness the bodies natural process to control protein levels and drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells as a unique therapeutic approach to treat a broad range of diseases. The company annual revenue is 17.8 million USD and 103 employees as on 2019. The headquarters is in USA.
    Company Website
    NURIX THERAPEUTICS, INC.

  9. Beam Therapeutics Inc.

    World Rank (Aug-2026)
    5,282
    Market Cap (Aug-2026)
    2.763 Billion USD
    World Rank (Jan-05-2024)
    5,482
    Market Cap (Jan-05-2024)
    2.121 Billion USD
    World Rank (Jul-30-2023)
    5,105
    Market Cap (Jul-30-2023)
    2.392 Billion USD
    World Rank (Dec-25-2022)
    4,254
    Market Cap (Dec-25-2022)
    2.844 Billion USD
    World Rank (Jan-07-2022)
    3,394
    Market Cap (Jan-07-2022)
    4.79 Billion USD
    Annual Revenue in USD
    140 Million USD
    Annual Operating Income in USD
    -384 Million USD
    Annual Net Income in USD
    -80 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile

    Beam Therapeutics is a Biotechnology company developing precision genetic medicines through the use of base editing. The headquarters is in USA.

    Facts About Company

    The company annual revenue is 60 million USD and net loss was -289 million USD as on Dec-2022.

    Company Website
    BEAM THERAPEUTICS INC.

  10. Momenta Pharmaceuticals

    World Rank (Aug-2026)
    5,297
    World Rank (Jan-05-2024)
    5,297
    World Rank (Jul-30-2023)
    5,297
    World Rank (Dec-25-2022)
    5,297
    World Rank (Jan-07-2022)
    5,297
    Annual Revenue in USD
    24 Million USD
    Annual Operating Income in USD
    -298 Million USD
    Annual Net Income in USD
    -290 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    USA
    Company Profile

    Momenta Pharmaceuticals is a Biotechnology company. The headquarters is in USA.

    Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD.

    Facts About Company

    Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD

    Company Website
    MOMENTA PHARMACEUTICALS INC

Share